Guttman-Yassky, E. ., Weidinger, S. ., Simpson, E. ., Gooderham, M. ., Irvine, A. ., Spelman, L. ., Silverberg, J. ., Elmaraghy, H. ., DeLuca-Carter, L. ., Buziqui Piruzeli, M. L. ., Hu, C. ., Yang, F. E. ., Pierce, E. ., Bardolet, L. . and Thaci, D. . (2023) “Efficacy and Safety of Lebrikizumab Is Maintained to Two Years in Patients With Moderate-to-Severe Atopic Dermatitis”, SKIN The Journal of Cutaneous Medicine, 7(6), p. s271. doi: 10.25251/skin.7.supp.271.